Thye Dirk
CIK 0001638945
Chief Executive OfficerDirector
Filings
12
Latest Jan 23, 2026
Issuers covered
1
Showing
12 of 12
Page 1
Track record
2 of 4 open-market trades scored (50% price coverage) - 2 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 2 | 100% | +12.1% | +12.1% | +12.3% | +12.0% |
| 90 days | 2 | 100% | +195.5% | +195.5% | +196.7% | +194.4% |
| 180 days | 2 | 100% | +92.2% | +92.2% | +92.5% | +91.9% |
| 365 days | 2 | 100% | +131.2% | +131.2% | +131.5% | +130.9% |
Issuers
Companies where Thye Dirk has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| QNCX | Quince Therapeutics, Inc. | 12 | Jan 23, 2026 |
All filings
12 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|